Cubist Systematic Strategies »

An2 Therapeutics shares owned by Cubist Systematic Strategies

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Cubist Systematic Strategies from 13F filings

Historical chart of Cubist Systematic Strategies investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Cubist Systematic Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Cubist Systematic Strategies

Quarter filed Position value Share count Share price at filing
2023-12-31 $338k 17k 20.49

More positions owned by Cubist Systematic Strategies

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Amazon (AMZN)
Apple (AAPL)
Uber Technologies (UBER)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Advanced Micro Devices (AMD)
Alibaba Group Hldg Sponsored Ads (BABA)
Zscaler Incorporated (ZS)
Netflix (NFLX)
Spotify Technology S A SHS (SPOT)
Super Micro Computer Call Option (SMCI)
Tesla Motors Call Option (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Microstrategy Cl A New (MSTR)

View all positions for Cubist Systematic Strategies

Top funds holding An2 Therapeutics

RA Capital Management
Citadel Advisors
Frazier Life Sciences Management
BVF
Henderson Group
Avidity Partners Management
Octagon Capital Advisors
Vanguard Group
Adage Capital Partners GP
BlackRock
Susquehanna International
Geode Capital Management
Acadian Asset Management
Walleye Trading Advisors
Alyeska Investment Group

View all funds holding An2 Therapeutics